Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Medchemcomm. 2013 Jan;4(1):130–134. doi: 10.1039/C2MD20175E

Fig. 3.

Fig. 3

Effects of CDPME, CBPME or CBPME2P on the rate of CMP formation catalyzed by IspF or the IspF–MEP complex, in the presence of 100 µM CDPME2P. Substrate analogs and MEP are added to a final concentration of 500 µM.